(Bloomberg) — An analysis of the most common uterine cancer suggests the disease should be reclassified into four categories that may help lead to more targeted treatments.

About a quarter of a group of women who would be thought to have a favorable outcome under traditional diagnosis, or 10% of all patients, actually have genetic changes suggesting they have a more serious disease and may be in need of more aggressive treatment, according to the research in the journal Nature. A second DNA study of cancer in the New England Journal of Medicine describes almost all the major mutations in acute myeloid leukemia.

Register or login for access to this item and much more

All Employee Benefit News content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access